Novo Nordisk | NVO - Capital Ordinário

Preço das Ações
36.83
Mudança Diária
-0.20 -0.54%
Mensal
-7.07%
Anual
-52.07%
Q1 Previsão
34.66




Capital Ordinário Alterar Data
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 56.71M 134.13K 2025-12
Bausch Health Companies USD 370.53M 59K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 368.28M 35.9M 2025-12
Corcept Therapeutics USD 105.97M 842K 2025-12
Drreddys Laboratories INR 832.57M 53K 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Merck USD 2.49B 15.79M 2025-09
Nektar Therapeutics USD 19K 0 2024-09
Novartis USD 1.91B 10.64M 2025-12
Novo Nordisk DKK 4.44B 0 2025-12
Novo Nordisk DKK 4.44B 3.99B 2025-06
Pacira USD 41.12M 1.85M 2025-12
Perrigo USD 137.6M 0 2025-12
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 48.08M 47.52M 2025-09
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Zoetis USD 424.93M 16.54M 2025-12